Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Segregated Nanocompartments Containing Therapeutic Enzymes and Imaging Compounds within DNA-Zipped Polymersome Clusters for Advanced Nanotheranostic Platform
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4607679
Author(s) Meyer, Claire E.; Liu, Juan; Craciun, Ioana; Wu, Dalin; Wang, Hui; Xie, Mingqi; Fussenegger, Martin; Palivan, Cornelia G.
Author(s) at UniBasel Palivan, Cornelia
Year 2020
Title Segregated Nanocompartments Containing Therapeutic Enzymes and Imaging Compounds within DNA-Zipped Polymersome Clusters for Advanced Nanotheranostic Platform
Journal Small
Volume 16
Number 27
Pages / Article-Number e1906492
Keywords catalytic nanocompartments, DNA polymersome clusters, dopamine, imaging nanocompartments, nanotheranostics
Abstract Abstract Nanotheranostics is an emerging field that brings together nanoscale-engineered materials with biological systems providing a combination of therapeutic and diagnostic strategies. However, current theranostic nanoplatforms have serious limitations, mainly due to a mismatch between the physical properties of the selected nanomaterials and their functionalization ease, loading ability, or overall compatibility with bioactive molecules. Herein, a nanotheranostic system is proposed based on nanocompartment clusters composed of two different polymersomes linked together by DNA. Careful design and procedure optimization result in clusters segregating the therapeutic enzyme human Dopa decarboxylase (DDC) and fluorescent probes for the detection unit in distinct but colocalized nanocompartments. The diagnostic compartment provides a twofold function: trackability via dye loading as the imaging component and the ability to attach the cluster construct to the surface of cells. The therapeutic compartment, loaded with active DDC, triggers the cellular expression of a secreted reporter enzyme via production of dopamine and activation of dopaminergic receptors implicated in atherosclerosis. This two-compartment nanotheranostic platform is expected to provide the basis of a new treatment strategy for atherosclerosis, to expand versatility and diversify the types of utilizable active molecules, and thus by extension expand the breadth of attainable applications.
URL https://onlinelibrary.wiley.com/doi/abs/10.1002/smll.201906492
edoc-URL https://edoc.unibas.ch/79769/
Full Text on edoc Available
Digital Object Identifier DOI 10.1002/smll.201906492
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/32130785
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.357 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024